Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 57: | Line 57: | ||
* | * | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left" | | ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Myelolipoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Fifth decade of life | |||
* | * | ||
| | | | ||
* Male = female | |||
| | | | ||
* More commonly seen in adrenal glands | |||
* Other possible locations include: | |||
* thoracic, retroperitoneum and presacral region, mediastinum, liver, and bone | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Usually asymptomatic | |||
* May cause abdominal pain, nausea, and constipation (depending on the location and size) | |||
* Uncommonly, may cause retro-peritoneal hemorrhage | |||
* 3 to 7 cm | |||
* | * | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* A combination of bone marrow elements and adipose tissue in varying proportions | |||
* May show myxoid changes | |||
* | * | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Well-circumscribed radiolucent mass in radiologic imaging | |||
* May have hromonal activity | |||
* | * | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC; " align="left" | | ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Spindle Cell/Pleomorphic Lipoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Fifth to seventh decades of life | |||
* | * | ||
| | | | ||
* Male > female | |||
| | | | ||
* More commonly seen in posterior neck, shoulder, and back | |||
* It is also reported in oral cavity | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Subcutaneous nodule with firm consistency | |||
* Slowly growing and painless | |||
* Mostly between 3 to 5 cm | |||
* | * | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Similar to ordinary lipoma | |||
* A combination of mature fat cells and spindle cell or pleomorphic elements | |||
* Lipomatous component may vary in amount | |||
* | * | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Immunohistochemically positive for CD34 | |||
* Benign | |||
* | * | ||
|- | |- | ||
!style="padding: 5px 5px; background: #DCDCDC; " align="left" | | !style="padding: 5px 5px; background: #DCDCDC; " align="left" |Chondroid Lipoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | |
Revision as of 20:46, 13 November 2019
Lipomatous tumor | Age of onset | Gender preponderance | Location | Clinical features | Diagnostic feature(s) | Other features |
---|---|---|---|---|---|---|
Angiolipoma |
|
|
|
|
|
|
Myolipoma |
|
|
|
|
|
|
Myelolipoma |
|
|
|
|
|
|
Spindle Cell/Pleomorphic Lipoma |
|
|
|
|
|
|
Chondroid Lipoma |
|
|
|
| ||
|
|
|
|
Example #1
The patient presented with S.O.B. one year after hysterectomy for a leiomyomatous uterus.